• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>AstraZeneca PLC ADR

AstraZeneca PLC ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. AstraZeneca Sets New Deadlines for MYSTIC Trial

    AstraZeneca Sets New Deadlines for MYSTIC Trial

  2. GlaxoSmithKline Global Pharmaceuticals President Abbas Hussain to Leave -- Update

    GlaxoSmithKline Global Pharmaceuticals President Abbas Hussain to Leave -- Update

  3. Adocia Announces the Transformation of Its Business Model to Increase the Value of Its Projects

    Adocia Announces the Transformation of Its Business Model to Increase the Value of Its Projects

  4. LONDON MARKETS: FTSE 100 Continues Record Run, Rising For 14th Day In A Row

    LONDON MARKETS: FTSE 100 Continues Record Run, Rising For 14th Day In A Row

  5. FTSE 100 continues record run, rising for 14th day in a row

    FTSE 100 continues record run, rising for 14th day in a row

  6. LONDON MARKETS: FTSE 100 Logs 10th Day Of All-time Highs

    LONDON MARKETS: FTSE 100 Logs 10th Day Of All-time Highs

  7. UPDATE: FTSE 100 logs 10th day of all-time highs

    UPDATE: FTSE 100 logs 10th day of all-time highs

  8. A.M. Best Assigns Credit Ratings to PASHA Insurance OJSC

    A.M. Best Assigns Credit Ratings to PASHA Insurance OJSC

  9. FiscalNote Opens Industry’s Only GRM Platform To European Data Amid Accelerated Global Expansion

    FiscalNote Opens Industry’s Only GRM Platform To European Data Amid Accelerated Global Expansion

  10. Chi-Med Initiates a Phase II Combination Study of Fruquintinib with Iressa® (gefitinib) in First-Line Non-Small Cell Lung Cancer

    Chi-Med Initiates a Phase II Combination Study of Fruquintinib with Iressa® (gefitinib) in First-Line Non-Small Cell Lung Cancer

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.